Tech Company Inital Public Offerings
Anacor Pharmaceuticals IPO
Operating out of Palo Alto, Anacor Pharmaceuticals is now a public company.
Transaction Overview
Company Name
Announced On
11/24/2010
Transaction Type
IPO
Amount
$60,000,000
Proceeds Purpose
Proceeds purposes are on file in company statements with the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1020 East Meadow Cir.
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Overview
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Berns
Chief Financial Officer
Geoffrey Parker
Chief Medical Officer
Lee Zane
VP - Bus. Development
Erik Wiberg
VP - Finance
James Marconi
VP - General Counsel
Ryan Sullivan
VP - Product Management
Kirk Maples
VP - R & D
Jacob Plattner
VP - Regulatory Affairs
Carmen Rodriguez
Browse more venture capital transactions:
Prev: 11/24/2010: Tasty Labs venture capital transaction
Next: 11/29/2010: ClickFox venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs